ClinicalTrials.gov
public full text
Public Domain
Behavioural Activation Therapy and Esketamine for Resistant Depression
This is a randomized clinical trial to test the effectiveness of combining a proven psychological intervention called behavioural activation therapy alongside esketamine treatment for treatment resistant major depressive episodes in individuals with major depressive disorder or bipolar disorder. Encouraging participants to practice new behaviours while their mood is improved through esketamine treatment may lead to more lasting recovery from depression.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- EMDR vs Supportive Therapy in Relapse Prevention in Traumatized Bipolar Patients#803731
- Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder#835901
- Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression#1137483
- Safety Evaluation of a Generative AI Agent for Anxiety and Depression Symptoms#146577
- Electroconvulsive Therapy (ECT) in Depression: The Role of Anhedonia#293035
Record · ID 838845
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive